606 related articles for article (PubMed ID: 15239085)
1. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
4. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
5. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
[TBL] [Abstract][Full Text] [Related]
6. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
[TBL] [Abstract][Full Text] [Related]
7. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
[TBL] [Abstract][Full Text] [Related]
9. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
10. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
11. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.
Tokushige K; Takakura M; Tsuchiya-Matsushita N; Taniai M; Hashimoto E; Shiratori K
J Hepatol; 2007 Jun; 46(6):1104-10. PubMed ID: 17395331
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
Crespo J; Cayón A; Fernández-Gil P; Hernández-Guerra M; Mayorga M; Domínguez-Díez A; Fernández-Escalante JC; Pons-Romero F
Hepatology; 2001 Dec; 34(6):1158-63. PubMed ID: 11732005
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
[TBL] [Abstract][Full Text] [Related]
15. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
16. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
Stejskal D; Růzicka V; Fanfrdlová G; Kolár V; Bartek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):93-9. PubMed ID: 16170395
[TBL] [Abstract][Full Text] [Related]
17. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
Musso G; Gambino R; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Cassader M; Durazzo M; Rizzetto M; Pagano G
Am J Gastroenterol; 2005 Nov; 100(11):2438-46. PubMed ID: 16279898
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
[TBL] [Abstract][Full Text] [Related]
19. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
[TBL] [Abstract][Full Text] [Related]
20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
